X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.prnewswire.com/news-releases/foresee-pharmaceuticals-receives-positive-recommendation-from-dsmb-to-continue-the-casppian-study-a-phase-3-clinical-trial-of-leuprolide-fp-001-injectable-emulsion-for-the-treatment-of-central-precocious-puberty-302104381.html
https://www.indianpharmapost.com/news/zydus-inks-licensing-agreement-with-daewoong-pharmaceutical-for-leuprolide-injectable-in-the-us-15000
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-4-2023-22726.pdf
https://www.prnewswire.com/news-releases/xtandi-enzalutamide-plus-leuprolide-reduced-the-risk-of-metastasis-by-58-in-non-metastatic-hormone-sensitive-prostate-cancer-versus-placebo-plus-leuprolide-301811445.html
https://www.fiercepharma.com/pharma/astellas-pfizer-look-broaden-xtandis-patient-base-new-prostate-cancer-win-after-8-years
https://www.prnewswire.com/news-releases/peptrons-pt105-a-sustained-release-leuprolide-established-the-bioequivalence-with-takedas-leuplin-301687409.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215336
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212963
https://www.prnewswire.com/news-releases/accord-biopharma-in-partnership-with-foresee-pharmaceuticals-launches-camcevi-leuprolide-injection-emulsion-in-the-us-for-the-treatment-of-advanced-prostate-cancer-in-adults-301516986.html
https://www.fiercepharma.com/pharma/takeda-guilty-breach-contract-spat-abbvie-over-supply-problems-prostate-cancer-drug-lupron
https://www.fiercepharma.com/pharma/no-dice-court-tells-abbvie-it-can-t-force-takeda-to-supply-a-drug-s-short-supply-worldwide
https://www.prnewswire.com/news-releases/tolmar-publishes-fensolvi--leuprolide-acetate-for-injectable-suspension-safety-and-efficacy-data-in-journal-of-clinical-endocrinology-and-metabolism-301179761.html
https://www.prnewswire.com/news-releases/tolmar-affirms-supply-of-fensolvi-leuprolide-acetate-for-pediatric-patients-with-central-precocious-puberty-301114208.html#:~:text=BUFFALO%20GROVE%2C%20Ill.%2C%20Aug,central%20precocious%20puberty%20(CPP).
https://www.prnewswire.com/news-releases/tolmar-affirms-full-supply-of-eligard-leuprolide-acetate-for-injectable-suspension-for-the-palliative-management-of-advanced-prostate-cancer-301109379.html
https://www.fiercepharma.com/manufacturing/takeda-hustles-to-prevent-cancer-drug-shortage-after-fda-warning-letter
https://www.prnewswire.com/news-releases/early-treatment-linked-to-reduced-joint-damage-in-young-adults-with-severe-hemophilia-a-301070219.html
https://www.ema.europa.eu/en/news/leuprorelin-depot-medicines-prac-recommends-new-measures-avoid-handling-errors
https://www.fiercebiotech.com/biotech/myovant-s-oral-prostate-cancer-drug-matches-incumbent-phase-3
https://www.fiercebiotech.com/biotech/myovant-s-oral-prostate-cancer-drug-matches-incumbent-phase-3
https://www.fiercebiotech.com/biotech/myovant-s-oral-prostate-cancer-drug-matches-incumbent-phase-3
https://www.clinicaltrialsarena.com/news/su2c-clinical-trials-teams-launch/
https://www.federalregister.gov/documents/2019/05/30/2019-11243/determination-that-lupron-leuprolide-acetate-injection-1-milligram02-milliliter-was-not-withdrawn
https://www.prnewswire.com/news-releases/foresee-pharmaceuticals-enters-exclusive-license-agreement-with-accord-healthcare-300792989.html
https://www.prnewswire.com/news-releases/enteris-biopharma-announces-positive-results-from-expanded-phase-2a-clinical-trial-of-ovarest-oral-leuprolide-tablet-for-endometriosis-300672192.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-16-2018-1526446624.pdf
https://www.prnewswire.com/news-releases/enteris-biopharma-announces-completion-of-recruitment-in-expanded-phase-2a-clinical-trial-of-ovarest-oral-leuprolide-tablet-for-endometriosis-300638439.html
https://www.statnews.com/2017/02/02/lupron-puberty-children-health-problems/
http://www.fiercebiotech.com/biotech/enteris-biopharma-signs-oral-diabetes-pact-sanofi
http://www.pmlive.com/pharma_news/allergan_plans_to_file_oral_uterine_fibroid_drug_in_us_by_year-end_1184383
http://www.fiercebiotech.com/biotech/myovant-bumps-up-ipo-to-218m-pfizer-bb-biotech-aid
http://www.fiercepharmamanufacturing.com/story/drug-shortages-becomes-issue-teva-and-mylan-hook/2015-04-30
Market Place
Share 
